Search Results - "Glendening, Michael J."
-
1
In vitro Loss of Heterozygosity Targets the PTEN/MMAC1 Gene in Melanoma
Published in Proceedings of the National Academy of Sciences - PNAS (04-08-1998)“…Gross genetic lesions of chromosome 10 occur in 30-50% of sporadic human melanomas. To test the functional significance of this observation, we have developed…”
Get full text
Journal Article -
2
Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds
Published in Oncogene (11-12-1997)“…Germline mutations within the cyclin-dependent kinase inhibitor 2A (CDKN2A) gene and one of its targets, the cyclin dependent kinase 4 (CDK4) gene, have been…”
Get full text
Journal Article -
3
Advanced Glycation End Products Contribute to Amyloidosis in Alzheimer Disease
Published in Proceedings of the National Academy of Sciences - PNAS (24-05-1994)“…Alzheimer disease (AD) is characterized by deposits of an aggregated 42-amino-acid β-amyloid peptide (βAP) in the brain and cerebrovasculature. After a…”
Get full text
Journal Article -
4
Localization of Multiple Melanoma Tumor–Suppressor Genes on Chromosome 11 by Use of Homozygosity Mapping-of-Deletions Analysis
Published in American journal of human genetics (01-08-2000)“…Loss-of-heterozygosity (LOH) studies have implicated one or more chromosome 11 tumor-suppressor gene(s) in the development of cutaneous melanoma as well as a…”
Get full text
Journal Article -
5
Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression
Published in Cancer research (Chicago, Ill.) (01-07-1995)“…Sporadic and familial malignant melanoma susceptibility has been linked to defects in the chromosomal region 9p21. Recently, a putative 9p21 tumor suppressor…”
Get full text
Journal Article -
6
Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets
Published in Genes chromosomes & cancer (01-06-1998)“…The cyclin‐dependent kinase inhibitor 2A (CDKN2A), or p16INK4a, gene on 9p21 is important in the genesis of both familial and sporadic melanoma. Homozygous…”
Get full text
Journal Article -
7
Low frequency of p16/CDKN2A methylation in sporadic melanoma: Comparative approaches for methylation analysis of primary tumors
Published in Cancer research (Chicago, Ill.) (01-12-1997)“…Methylation of the 5' CpG island of the p16 tumor suppressor gene represents one possible mechanism for inactivation of this cell cycle regulatory gene that is…”
Get full text
Journal Article -
8
Virtually 100% of melanoma cell lines harbor alterations at the DNA level withinCDKN2A, CDKN2B, or one of their downstream targets
Published in Genes chromosomes & cancer (01-06-1998)Get full text
Journal Article -
9
Homozygous loss of the p15INK4B gene (and not the p1-INK4 gene) during tumor progression in a sporadic melanoma patient
Published in Cancer research (Chicago, Ill.) (01-12-1995)“…Homozygous deletions of 9p21, including the cyclin-dependent kinase inhibitor genes p16INK4 and p15INK4B, have been reported frequently in melanoma (as well as…”
Get full text
Journal Article -
10
Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds
Published in Human molecular genetics (01-10-1995)“…The cyclin dependent kinase inhibitor 2 (CDKN2) gene on chromosome 9p21 is potentially involved in the genesis of many cancers and is currently under intense…”
Get more information
Journal Article -
11
Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma
Published in Cancer research (Chicago, Ill.) (01-11-1996)“…Although homozygous deletions of the cyclin-dependent kinase inhibitor 2 gene p16INK4a on 9p21 have been reported frequently in metastatic melanoma cell lines,…”
Get full text
Journal Article